Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.770
-0.025 (-1.39%)
At close: May 30, 2025, 4:00 PM
1.840
+0.070 (3.95%)
After-hours: May 30, 2025, 4:05 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $49.46 million as of May 30, 2025. Its market cap has increased by 13.22% in one year.
Market Cap
49.46M
Enterprise Value
40.76M
1-Year Change
13.22%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $49.46M, a decrease of -60.32%. That is a compound annual growth rate of -19.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 49.88M | -12.94% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.06B |
| Johnson & Johnson | 368.73B |
| AbbVie | 328.06B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 267.61B |
| Abbott Laboratories | 231.29B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |